NDA 022029 · Hisamitsu Pharm CO
Salonpas
Menthol, Methyl Salicylate · Topical
Last checked: Nov 20, 2026Latest source record: Oct 6, 2025 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2008
Feb 20, 2008
Approved uses
3
Original approval plus efficacy supplements
Registered trials
107
20 Phase 3, 5 recruiting
FAERS reports
37,817
29,306 serious, 7,326 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Mar 13, 2026.
INDICATIONS & USAGE SECTION
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Mar 29, 2013 Supplement 12 · Efficacy Pediatric Medical ReviewPediatric Medical ReviewPediatric Clinical Pharmacology Review
- Nov 5, 2012 Supplement 11 · Efficacy LabelLetter
- Feb 20, 2008 Original approval · Type 3 - New Dosage Form and Type 4 - New Combination ReviewSummary ReviewLetter
2 products under this application
- SALONPAS · MENTHOL 3%; METHYL SALICYLATE 10% · PATCH, TOPICAL · Over-the-counter
- SALONPAS · MENTHOL 3%; METHYL SALICYLATE 10% · PATCH, TOPICAL · Over-the-counter
Clinical trials
Interventional ClinicalTrials.gov studies with "Menthol" as an intervention, any sponsor and status, largest first.
- Topical Piroxicam vs Soulagel in the Treatment of Acute Extremity Pain After Emergency Department DischargePivotal-lookingCompleted
University of MonastirAcademic, hospital or other
NCT05054023 · 1,525 participants · Start Oct 21, 2021 · Primary completion Mar 21, 2022
Drug: Soulagel®; Arthrosyl® · For: Acute Pain
Sites: Monastir, Tunisia
- Impact of Very Low Nicotine Content Cigarettes in a Complex MarketplacePivotal-lookingCompleted
University of MinnesotaAcademic, hospital or other
NCT03272685 · 799 participants · Start Jun 1, 2018 · Primary completion Sep 30, 2022
Drug: Very Low Nicotine Content Cigarettes; Normal Nicotine Content Cigarettes · For: Tobacco Smoking; Nicotine Dependence
Sites: San Francisco, California; Minneapolis, Minnesota; Durham, North Carolina · 6 sites in all
- ARomatherapy for Cognitive Trajectory in Chinese After Percutaneous Coronary Intervention (ARCTIC-PCI)Pivotal-lookingStatus unknown
Beijing Anzhen HospitalAcademic, hospital or other
NCT04103086 · 660 participants (planned) · Start Dec 2019 · Primary completion Dec 2020
Drug: Aromatherapy; Placebo · For: Percutaneous Coronary Intervention
- Modeling Tobacco Regulatory Impacts in Appalachia Using the Experimental Tobacco MarketplacePivotal-lookingEnrolling by invitation
Mikhail N KoffarnusAcademic, hospital or other
NCT06234722 · 473 participants (planned) · Start Aug 16, 2024 · Primary completion Feb 2028
Drug: Very Low Nicotine Cigarette · For: Tobacco Use; Cigarette Use
Sites: Lexington, Kentucky
- ARomatherapy for Cognitive Trajectory in Chinese After Coronary Artery Bypass GraftingPivotal-lookingStatus unknown
Beijing Anzhen HospitalAcademic, hospital or other
NCT04102696 · 460 participants (planned) · Start Dec 2019 · Primary completion Dec 2020
Drug: Aromatherapy; Placebo · For: Coronary Artery Bypass Grafting; Myocardial Infarction
- Effect of Intraluminal Administration of Menthol Solution During Colonoscopy on Colonic Spasm and Adenoma Detection RatePivotal-lookingNot yet recruiting
The First Affiliated Hospital of Zhengzhou UniversityAcademic, hospital or other
NCT07501962 · 440 participants (planned) · Start Apr 1, 2026 · Primary completion Dec 31, 2026
Drug: Endoscopic irrigation was performed using a 0.1% menthol solution combined with simethicone.; Endoscopic irrigation was performed using an aqueous suspension prepared with simethicone and normal saline. · For: Colonoscopy
- Comparison of Nicotine Replacement Therapy and Electronic Cigarettes for Smoking Cessation in PakistanPivotal-lookingStatus unknown
Strategic Health Research LimitedResearch network
NCT06063421 · 438 participants (planned) · Start Jun 1, 2024 · Primary completion May 31, 2025
Drug: Nicotine Replacement Therapy · For: Smoking Cessation; Electronic Cigarette Use
Sites: Islamabad, Pakistan
- Yanlishuang Buccal Dropping Pills for Acute PharyngitisPivotal-lookingNot yet recruiting
Beijing University of Chinese MedicineAcademic, hospital or other
NCT07761013 · 400 participants (planned) · Start Dec 2026 · Primary completion Mar 26, 2027
Drug: Yanlishuang Buccal Dropping Pills; Yanlishuang Buccal Dropping Pills Placebo · For: Acute Pharyngitis
Sites: Guangzhou, China; Guiyang, China; Harbin, China · 10 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- drug ineffective8,004
- pain7,680
- fatigue7,245
- rheumatoid arthritis6,543
- rash6,293
- abdominal discomfort6,172
- off label use6,019
- systemic lupus erythematosus6,006
- alopecia5,903
- glossodynia5,881
- pemphigus5,836
- swelling5,561
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 432 |
| 2005 | 490 |
| 2006 | 454 |
| 2007 | 606 |
| 2008 | 749 |
| 2009 | 561 |
| 2010 | 794 |
| 2011 | 1,184 |
| 2012 | 905 |
| 2013 | 330 |
| 2014 | 391 |
| 2015 | 620 |
| 2016 | 1,082 |
| 2017 | 1,194 |
| 2018 | 1,762 |
| 2019 | 1,883 |
| 2020 | 2,343 |
| 2021 | 3,135 |
| 2022 | 3,363 |
| 2023 | 3,470 |
| 2024 | 5,038 |
| 2025 | 4,363 |
| 2026 | 2,666 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Herbal treatments for migraine: A systematic review of randomised-controlled studies.
Lopresti AL, Smith SJ, Drummond PD · Phytother Res 2020 · Systematic Review
- Primary Localized Cutaneous Amyloidosis: A Systematic Treatment Review.
Weidner T, Illing T, Elsner P · Am J Clin Dermatol 2017 · Systematic Review
- Topical therapies for knee osteoarthritis.
Rodriguez-Merchan EC · Postgrad Med 2018 · Systematic Review
- Inducible desensitization to capsaicin with repeated low-dose exposure in human volunteers.
Nolden AA, Lenart G, Spielman AI, et al. · Physiol Behav 2024 · Randomized Controlled Trial, Research Support, U.S. Gov't, Non-P.H.S.
- Olfactory stimulation may modulate the sensation of nasal patency.
Chao YT, Nakov A, Haehner A, et al. · Rhinology 2023 · Randomized Controlled Trial
- To quit or not: Vulnerability of women to smoking tobacco.
Park SJ, Yi B, Lee HS, et al. · J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2016 · Research Support, Non-U.S. Gov't, Systematic Review
Sponsor: Hisamitsu Pharm CO
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.